This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Explore effective ways to monetize your blog or website. Learn proven strategies to boost your online income and achieve success.
8,001 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
As of May 2026, the U.S. tech economy hinges on institutional design that turns ideas into markets. This piece explai...
This deep dive breaks down seadrill (sdrl) 2026 earnings trends, what the Q1 2026 transcript signals for the fleet an...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
NVIDIA gains from a limited export-license shift that allows select Chinese firms to buy its top AI accelerators, but...
Nvidia shares jumped after U.S. officials cleared exports of advanced AI processors to Chinese firms, sparking a rall...
Online fame built on controversy can bring money, but it also carries real financial risks. This article explains how...
Solana (HSDT) 2026 earnings reveal momentum in Q1 amid growing on-chain activity and ecosystem expansion. This guide ...
A growing cadre of investors is exploring whether a Tesla-SpaceX merger could become a true berkshire hathaway inside...
SoundHound AI stock has slipped in 2026, leaving investors to weigh risk against opportunity. This guide breaks down ...